Fan X
Institute of Oncology, Beijing.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1993 Feb;15(1):71-3.
The model of precancerous lesions of the bladder in rats was induced by N-butyl-(4-hydroxybutyl) nitrosamide (BBN). The animals were randomly divided into the following 3 groups: 1) given Antitumor-B (Chinese herbs); 2) given 4-ethoxycarbophenylretinamide (Retinamide); and 3) control. After treatment for 13 months the rats were killed for pathomorphological examination of the bladder. The results showed that the incidence of bladder cancer in group 1 and 2 was reduced by 90.7% (P < 0.01) and 75.0% (P < 0.01) respectively after treatment as compared with the control group. Our results provide a useful reference for clinical trial in the prevention of bladder cancer recurrence by using antitumor-B and Retinamide.
采用N-丁基-(4-羟基丁基)亚硝胺(BBN)诱导大鼠膀胱癌前病变模型。将动物随机分为以下3组:1)给予抗肿瘤B号(中药);2)给予4-乙氧羰基苯基维甲酸(维甲酰胺);3)对照组。治疗13个月后处死大鼠,对膀胱进行病理形态学检查。结果显示,与对照组相比,治疗后第1组和第2组膀胱癌的发生率分别降低了90.7%(P<0.01)和75.0%(P<0.01)。我们的结果为使用抗肿瘤B号和维甲酰胺预防膀胱癌复发的临床试验提供了有用的参考。